These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21829131)

  • 21. Absorption, metabolism, and excretion of intravenously and orally administered [14C]telmisartan in healthy volunteers.
    Stangier J; Schmid J; Türck D; Switek H; Verhagen A; Peeters PA; van Marle SP; Tamminga WJ; Sollie FA; Jonkman JH
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1312-22. PubMed ID: 11185629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of angiotensin II receptor blockers in the dog following a single oral administration.
    Baek IH; Lee BY; Lee ES; Kwon KI
    Drug Res (Stuttg); 2013 Jul; 63(7):357-61. PubMed ID: 23539423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renoprotective effects of telmisartan in the 5/6 nephrectomised rats.
    Tsunenari I; Ohmura T; Seidler R; Chachin M; Hayashi T; Konomi A; Matsumaru T; Sumida T; Hayashi N; Horie Y
    J Renin Angiotensin Aldosterone Syst; 2007 Jun; 8(2):93-100. PubMed ID: 17703436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of single-dose telmisartan 120 mg given during and between hemodialysis in subjects with severe renal insufficiency: comparison with healthy volunteers.
    Stangier J; Su CA; Brickl R; Franke H
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1365-72. PubMed ID: 11185635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liquid chromatographic-tandem mass spectrometric method for the simultaneous quantitation of telmisartan and hydrochlorothiazide in human plasma.
    Yan T; Li H; Deng L; Guo Y; Yu W; Fawcett JP; Zhang D; Cui Y; Gu J
    J Pharm Biomed Anal; 2008 Dec; 48(4):1225-9. PubMed ID: 18838240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of repeated oral doses of amlodipine and amlodipine plus telmisartan in healthy volunteers.
    Stangier J; Su CA
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1347-54. PubMed ID: 11185633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. UGT1A1*28 genotype affects the in-vitro glucuronidation of thyroxine in human livers.
    Yoder Graber AL; Ramírez J; Innocenti F; Ratain MJ
    Pharmacogenet Genomics; 2007 Aug; 17(8):619-27. PubMed ID: 17622938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucuronidation of antiallergic drug, Tranilast: identification of human UDP-glucuronosyltransferase isoforms and effect of its phase I metabolite.
    Katoh M; Matsui T; Yokoi T
    Drug Metab Dispos; 2007 Apr; 35(4):583-9. PubMed ID: 17220234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of angiotensin II receptor blocker lipophilicities and their protective effect against vascular remodeling.
    Takai S; Kirimura K; Jin D; Muramatsu M; Yoshikawa K; Mino Y; Miyazaki M
    Hypertens Res; 2005 Jul; 28(7):593-600. PubMed ID: 16335888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of pharmacogenetics on deferasirox AUC and efficacy.
    Cusato J; Allegra S; De Francia S; Massano D; Piga A; D'Avolio A
    Pharmacogenomics; 2016 Apr; 17(6):561-72. PubMed ID: 27043265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of oral doses of telmisartan and nisoldipine, given alone and in combination, in patients with essential hypertension.
    Bajcetic M; Benndorf RA; Appel D; Schwedhelm E; Schulze F; Riekhof D; Maas R; Böger RH
    J Clin Pharmacol; 2007 Mar; 47(3):295-304. PubMed ID: 17322141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic-pharmacodynamic modeling of telmisartan using an indirect response model in spontaneously hypertensive rats.
    Hao K; Chen YC; Cao YG; Yu D; Liu XQ; Wang GJ
    Acta Pharmacol Sin; 2007 May; 28(5):738-43. PubMed ID: 17439731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a Pharmacokinetic Interaction between Telmisartan and Chlorthalidone in Healthy Male Adult Subjects.
    Seong SJ; Lim MS; Lee J; Ohk B; Gwon MR; Kim BK; Kim HJ; Yang DH; Lee HW; Kang WY; Yoon YR
    Clin Drug Investig; 2016 Aug; 36(8):613-23. PubMed ID: 27206575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of raltegravir in individuals with UGT1A1 polymorphisms.
    Wenning LA; Petry AS; Kost JT; Jin B; Breidinger SA; DeLepeleire I; Carlini EJ; Young S; Rushmore T; Wagner F; Lunde NM; Bieberdorf F; Greenberg H; Stone JA; Wagner JA; Iwamoto M
    Clin Pharmacol Ther; 2009 Jun; 85(6):623-7. PubMed ID: 19279563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acyl glucuronidation of fluoroquinolone antibiotics by the UDP-glucuronosyltransferase 1A subfamily in human liver microsomes.
    Tachibana M; Tanaka M; Masubuchi Y; Horie T
    Drug Metab Dispos; 2005 Jun; 33(6):803-11. PubMed ID: 15769885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human metabolism of nebicapone (BIA 3-202), a novel catechol-o-methyltransferase inhibitor: characterization of in vitro glucuronidation.
    Loureiro AI; Bonifácio MJ; Fernandes-Lopes C; Almeida L; Wright LC; Soares-Da-Silva P
    Drug Metab Dispos; 2006 Nov; 34(11):1856-62. PubMed ID: 16790555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.
    Udomuksorn W; Elliot DJ; Lewis BC; Mackenzie PI; Yoovathaworn K; Miners JO
    Pharmacogenet Genomics; 2007 Dec; 17(12):1017-29. PubMed ID: 18004206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue-specific peroxisome proliferator activated receptor gamma expression and metabolic effects of telmisartan.
    Zídek V; Mlejnek P; Simáková M; Silhavy J; Landa V; Kazdová L; Pravenec M; Kurtz TW
    Am J Hypertens; 2013 Jun; 26(6):829-35. PubMed ID: 23426788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety, efficacy, and pharmacokinetics of telmisartan in pediatric patients with hypertension.
    Wells TG; Portman R; Norman P; Haertter S; Davidai G; Fei Wang
    Clin Pediatr (Phila); 2010 Oct; 49(10):938-46. PubMed ID: 20724342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Both cMOAT/MRP2 and another unknown transporter(s) are responsible for the biliary excretion of glucuronide conjugate of the nonpeptide angiotensin II antagonist, telmisaltan.
    Nishino A; Kato Y; Igarashi T; Sugiyama Y
    Drug Metab Dispos; 2000 Oct; 28(10):1146-8. PubMed ID: 10997931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.